Status:
RECRUITING
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Lead Sponsor:
Public Health Foundation Enterprises, Inc.
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
University of California, San Francisco
Conditions:
HIV Infections
Sexually Transmitted Diseases
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directe...
Detailed Description
This is a clinic-based, multi-site, randomized, two-arm study to compare the effectiveness of two mobile technologies designed to support PrEP adherence and continuation in cisgender and transgender m...
Eligibility Criteria
Inclusion
- Self-identifies as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum)
- Report sex with a cisgender man or transgender woman or any individual assigned male sex at birth in the past 12 months
- Age 15 years or older
- Willing and able to provide written informed consent
- Owns an iOS or Android mobile phone and able to access the internet and send and receive text messages
- Able to understand, read, and speak English or Spanish
- Newly initiated PrEP or currently on PrEP and at risk for PrEP discontinuation based on at least one of the following:
- Initiated PrEP within the past 6 months, or
- Has any of the following risk factors for PrEP discontinuation: missed clinic visits; age \< 30; African-American or Latino; transgender gender identity; or self-reported illicit substance use
Exclusion
- Currently enrolled in another PrEP intervention study
- Unable to complete 12 month study participation
- Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Key Trial Info
Start Date :
July 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04855773
Start Date
July 21 2021
End Date
August 1 2023
Last Update
September 28 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Bridge HIV, San Francisco Department of Public Health
San Francisco, California, United States, 94102
2
San Francisco AIDS Foundation
San Francisco, California, United States, 94114
3
Whitman-Walker Health
Washington D.C., District of Columbia, United States, 20009
4
University of Miami
Miami, Florida, United States, 33136